Albumin corona on nanoparticles–a strategic approach in drug delivery

Drug Delivery

Volumn 23, Issue 8, 2016, Pages 2668-2676

  Mariam, Jessy ^a   Sivakami, S ^a   Dongre, Prabhakar M ^a  

^a UNIVERSITY OF MUMBAI   (India)

Author keywords

Albumin; drug delivery; nanoparticles

Indexed keywords

ALBUMIN; BOVINE SERUM ALBUMIN; CARBON NANOTUBE; DRUG CARRIER; GOLD NANOPARTICLE; MAGNETIC NANOPARTICLE; NANOCARRIER; NANOMATERIAL; NANOPARTICLE; PHOSPHOLIPID; POLYMER; QUANTUM DOT; SILICA NANOPARTICLE; SILVER NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

CIRCULATION TIME; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; DRUG CLEARANCE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG RELEASE; DRUG STABILITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE SPECIFICITY; ANIMAL; CHEMISTRY; PHYSIOLOGY; PROCEDURES; TISSUE DISTRIBUTION;

ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; NANOSTRUCTURES; SERUM ALBUMIN, BOVINE; TISSUE DISTRIBUTION;

EID: 84996569960     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2015.1048488     Document Type: Review

References (71)

1. Arbós P, Arangoa M, Campanero M, Irache J. (2002). Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles. Int J Pharm 242:129–36
2. Asadishad B, Vossoughi M, Alemzadeh. (2010). Folate-receptor-targeted delivery of doxorubicin using polyethylene glycol-functionalized gold nanoparticles. Ind Eng Chem Res 49:1958–63
3. Bardhan M, Mandal G, Ganguly T. (2009). Steady state, time resolved, and circular dichroism spectroscopic studies to reveal the nature of interactions of zinc oxide nanoparticles with transport protein bovine serum albumin and to monitor the possible protein conformational changes. J Appl Phys 106:034701–5
4. Bhogale A, Patel N, Mariam J, et al. (2014). Comprehensive studies on the interaction of copper nanoparticles with bovine serum albumin using various spectroscopies. Colloids Surf B Biointerfaces 113:276–84
5. Bhogale A, Patel N, Sarpotdar P, et al. (2013). Systematic investigation on the interaction of bovine serum albumin with ZnO nanoparticles using fluorescence spectroscopy. Colloids Surf B Biointerfaces 102:257–64
6. Borchard G, Kreuter J. (1993). Interaction of serum components with poly(methylmethacrylate) nanoparticles and the resulting body distribution after intravenous injection in rats. J Drug Target 1:15–19
7. Chakraborty S, Joshi P, Shanker V, et al. (2011). Contrasting effect of gold nanoparticles and nanorods with different surface modifications on the structure and activity of bovine serum albumin. Langmuir 27:7722–31
8. Chen RC, Schurr RN, Bhattacharya P, et al. (2012). Interaction of lipid vesicle with silver nanoparticle-serum albumin protein corona. Appl Phys Lett 100:013703-1–4
9. Churchman AH, Wallace R, Milne SJ, et al. (2013). Serum albumin enhances the membrane activity of ZnO nanoparticles. Chem Commun 49:4172–4
10. Cifuentes-Rius A, de Puig H, Kah JCY, et al. (2013). Optimizing the properties of the protein corona surrounding nanoparticles for tuning payload release. ACS Nano 7:10066–74
11. De Paoli SH, Diduch LL, Tegegn TZ, et al. (2014). The effect of protein corona composition on the interaction of carbon nanotubes with human blood platelets. Biomaterials 35:6182–94
12. Desai N, Abraxis BioScience Inc. (2007). Nanoparticle albumin bound (nab) technology:targeting tumors through the endothelial gp60 receptor and SPARC. Nanomedicine 3:337–46
13. Dieni C, Stone C, Armstrong M, et al. (2013). Spherical gold nanoparticles impede the function of bovine serum albumin in vitro:a new consideration for studies in nanotoxicology. J Nanomater Mol Nanotechnol 2:6. doi:10.4172/2324-8777.1000124
14. Dobrovolskaia MA, Patri AK, Zheng J, et al. (2009). Interaction of colloidal gold nanoparticles with human blood:effects on particle size and analysis of plasma protein binding profiles. Nanomedicine 5:106–17
15. Fleischer C, Payne C. (2014). Nanoparticle-cell interactions:molecular structure of the protein corona and cellular outcomes. Acc Chem Res 47:2651–9
16. Gao D, Tian Y, Bi S, et al. (2005). Studies on the interaction of colloidal gold and serum albumins by spectral methods. Spectrochim Acta A 62:1203–8
17. Gao D, Tian Y, Liang F, et al. (2006). Investigation on the interaction between colloidal gold and human complement factor 4 at different pH by spectral methods. Colloid Surf B 47:71–7
18. 2 quantum dots/poly(L-glutamic acid)–drug conjugates for drug delivery and cell imaging. Analyst 139:831–6
19. Garza-Ocañas L, Ferrer DA, Burt J, et al. (2010). Biodistribution and long-term fate of silver nanoparticles functionalized with bovine serum albumin in rats. Metallomics 2:204–10
20. Gaur KP, Mishra S, Bajpai M, Mishra A. (2014). Enhanced oral bioavailability of efavirenz by solid lipid nanoparticles:in vitro drug release and pharmacokinetics studies. Biomed Res Int 2014:363404
21. Goy-López S, Juárez J, Alatorre-Meda M, et al. (2012). Physicochemical characteristics of protein–NP bioconjugates:the role of particle curvature and solution conditions on human serum albumin conformation and fibrillogenesis inhibition. Langmuir 28:9113–26
22. Jhonsi M, Kathiravan A, Renganathan R. (2009). Spectroscopic studies on the interaction of colloidal capped CdS nanoparticles with bovine serum albumin. Colloid Surf B 72:167–72
23. Joshi P, Chakraborty S, Dey S, et al. (2011). Binding of chloroquine-conjugated gold nanoparticles with bovine serum albumin. J Colloid Interface Sci 355:402–9
24. Jung B, Anvari B. (2012). Synthesis and characterization of bovine serum albumin-coated nanocapsules loaded with indocyanine green as potential multifunctional nanoconstructs. Biotechnol Prog 28:533–9
25. Jung SK, Kim SK, Jung SH, et al. (2010). Increased stability in plasma and enhanced cellular uptake of thermally denatured albumin-coated liposomes. Colloids Surf B Biointerfaces 76:434–40
26. 2 with human serum albumin:a fluorescence quenching study. Colloid Surf A 333:91–5
27. 2 nanoparticles with bovine serum albumin. Polyhedron 28:157–61
28. 2 with bovine serum albumin. Colloid Surf A 324:176–80
29. Khullar P, Singh V, Mahal A, et al. (2012). Bovine serum albumin bioconjugated gold nanoparticles:synthesis, hemolysis and cytotoxicity toward cancer cell lines. J Phys Chem C 116:8834–43
30. Kong L, Hu J, Qin D, Yan P. (2015). Interaction of ifosfamide-loaded superparamagnetic iron oxide nanoparticles with human serum albumin–a biophysical study. J Pharm Innov 10:13–20
31. Koo O, Rubinstein I, Onyuksel H. (2005). Role of nanotechnology in targeted drug delivery and imaging:a concise review. Nanomedicine 1:193–212
32. Kummitha CM, Malamas AS, Lu Z. (2012). Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles. Int J Nanomed 7:5205–14
33. Landry F, Bazile D, Spenlehauer G, et al. (1998). Peroral administration of 14C-poly(D,L-lactic acid) nanoparticles coated with human serum albumin or polyvinyl alcohol to guinea pigs. J Drug Target 6:293–307
34. Landry FB, Bazile DV, Spenlehauer VM. (1996). Degradation of poly(d,l-lactic acid) nanoparticles coated with albumin in model digestive fluids (USP XXII). Biomaterials 17:715–23
35. Li C, Xing L, Che S. (2012). Coordination bonding based pH-responsive albumin nanoparticles for anticancer drug delivery. Dalton Trans 41:3714–19
36. Liu Y, Ji F, Liu R. (2013). The interaction of bovine serum albumin with doxorubicin-loaded superparamagnetic iron oxide nanoparticles:spectroscope and molecular modelling identification. Nanotoxicology 7:97–104
37. Lu W, Wan J, She Z, Jiang X. (2007). Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. J Control Release 118:38–53
38. Lu W, Zhang Y, Tan Y, et al. (2005). Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Control Release 107:428–48
39. Ma Z, Bai J, Wang Y, Jiang X. (2014). Impact of shape and pore size of mesoporous silica nanoparticles on serum protein adsorption and RBCs hemolysis. ACS Appl Mater Interfaces 6:2431–8
40. Maffre P, Brandholt S, Nienhaus K, et al. (2014). Effects of surface functionalization on the adsorption of human serum albumin onto nanoparticles–a fluorescence correlation spectroscopy study. Beilstein J Nanotechnol 5:2036–47
41. Mariam J, Dongre P, Kothari D. (2011). Study of interaction of silver nanoparticles with bovine serum albumin using fluorescence spectroscopy. J Fluoresc 21:2193–9
42. Mariam J, Sivakami S, Kothari D, Dongre P. (2014). Bioactivity of albumins bound to silver nanoparticles. Protein J 33:258–66
43. Marucco A, Fenoglio I, Turci F, Fubini B. (2013). Interaction of fibrinogen and albumin with titanium dioxide nanoparticles of different crystalline phases. J Phys Conf Ser 429:012014
44. Monopoli MP, Aberg C, Salvati A, Dawson KA. (2012). Biomolecular coronas provide the biological identity of nanosized materials. Nat Nano 7:779–86
45. Mortimer GM, Butcher NJ, Musumeci AW, et al. (2014). Cryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterials. ACS Nano 8:3357–66
46. Nigam P, Waghmode S, Louis M, et al. (2014). Graphene quantum dots conjugated albumin nanoparticles for targeted drug delivery and imaging of pancreatic cancer. J Mater Chem B 2:3190–5
47. Pan B, Cui D, Xu P, et al. (2007). Study on interaction between gold nanorod and bovine serum albumin. Colloid Surf A 295:217–22
48. Pan B, Gao F, Ao L. (2005). Investigation of interactions between dendrimer-coated magnetite nanoparticles and bovine serum albumin. J Magn Magn Mater 293:252–8
49. Peng Q, Wei X, Shao X, et al. (2014). Nanocomplex based on biocompatible phospholipids and albumin for long-circulation applications. ACS Appl Mater Interfaces 6:13730–7
50. Peng Q, Zhang S, Yang Q, et al. (2013). Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. Biomaterials 34:8521–30
51. Peters T. (1996). All about albumin:biochemistry, genetics and medical applications. San Diego:Academic Press
52. Pramanik S, Banerjee P, Sarkar A, Bhattacharya SC. (2008). Size-dependent interaction of gold nanoparticles with transport protein:a spectroscopic study. J Lumin 128:1969–74
53. Qi J, Yao P, He F, et al. (2010). Nanoparticles with dextran/chitosan shell and BSA/chitosan core–doxorubicin loading and delivery. Int J Pharm 393:176–84
54. Quan Q, Xie J, Gao H, et al. (2011). HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy. Mol Pharm 8:1669–76
55. Ramezani F, Amanlou M, Rafii-Tabar H. (2014). Gold nanoparticle shape effects on human serum albumin corona interface:a molecular dynamic study. J Nanopart Res doi:10.1007/s11051-014-2512-1
56. Rastogi L, Kora A, Arunachalam J. (2012). Highly stable, protein capped gold nanoparticles as effective drug delivery vehicles for amino-glycosidic antibiotics. Mater Sci Eng C Mater Bio Appl 32:1571–7
57. Ravindran A, Singh A, Raichur A, et al. (2010). Studies on interaction of colloidal Ag nanoparticles with bovine serum albumin (BSA). Colloid Surf B 76:32–7
58. Salvati A, Aberg C, dos Santos T, et al. (2011). Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules:toward models of uptake kinetics. Nanomedicine 7:818–26
59. Samsonova YS, Priezzhev AV, Lugovtsov AE, et al. (2012). Investigation of interaction of albumin molecules with diamond nanoparticles in aqueous solutions by dynamic light scattering. Quantum Electron 42:484–488
60. Shang L, Wang Y, Jiang J, Dong S. (2007). pH dependent protein conformational change in albumin:gold nanoparticle bioconjugates:a spectroscopic study. Langmuir 23:2714–21
61. Singh AV, Bandgar BM, Kasture M, et al. (2005). Synthesis of gold, silver and their alloy nanoparticles using bovine serum albumin as foaming and stabilizing agent. J Mater Chem 15:5115–21
62. Sripriyalakshmi S, Anjali CH, Doss G, et al. (2014). BSA nanoparticle loaded atorvastatin calcium–a new facet for an old drug. Plos One 9:1–10
63. Tao X, Zhang Q, Ling K, et al. (2012). Effect of pullulan nanoparticle surface charges on HSA complexation and drug release behavior of HSA-bound nanoparticles. PLos One 7:e49304
64. Vauthier C, Lindner P, Cabane B. (2009). Configuration of bovine serum albumin adsorbed on polymer particles with grafted dextran corona. Colloids Surf B Biointerfaces 69:207–15
65. Vroman L, Adams A, Fischer G, Munoz P. (1980). Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plamsa at interfaces. Blood 55:156–9
66. Vishnu P, Roy V. (2011). Safety and efficacy of nab-paclitaxel in the treatment of patients with breast cancer. Breast Cancer 5:53–65
67. Weecharangsan W, Yu B, Zheng Y, et al. (2009). Efficient delivery of antisense oligodeoxyribonucleotide G3139 by human serum albumin-coated liposomes. Mol Pharm 6:1848–55
68. Xia B, Zhang W, Shi J, Xiao S. (2013). Engineered stealth porous silicon nanoparticles via surface encapsulation of bovine serum albumin for prolonging blood circulation in vivo. ACS Appl Mater Interfaces 5:11718–24
69. Yang Q, Liang J, Han H. (2009). Probing the interaction of magnetic iron oxide nanoparticles with bovine serum albumin by spectroscopic techniques. J Phys Chem B 113:10454–8
70. Zaloga J, Janko C, Nowak J, et al. (2014). Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility. Int J Nanomed 9:4847–66
71. Zhang C, Cao J, Yin D, et al. (2004). Preparation and radiolabeling of human serum albumin (HSA)-coated magnetite nanoparticles for magnetically targeted therapy. Appl Radiat Isot 61:1255–9